GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Azenta Inc.
Azenta (formerly Brooks Automation) is a company focused on life science solutions, particularly automated biological sample storage. Its stock price reflects growing investment in pharmaceutical research and personalized medicine.
Share prices of companies in the market segment - Diagnostic medical equipment
Azenta is a company focused on life science solutions, with key segments in automated biospecimen storage and genomic services. We classify it as part of the Diagnostic Medical Equipment sector, and the chart below reflects the dynamics of the entire biotechnology equipment industry.
Broad Market Index - GURU.Markets
Azenta is a leading provider of life science solutions, including automated biological sample storage systems and genomic services. Its key role in this field makes it a key component of the GURU.Markets index. The chart below represents the entire market. Find out how Azenta compares to it.
Change in the price of a company, segment, and market as a whole per day
AZTA - Daily change in the company's share price Azenta Inc.
Daily fluctuations in Azenta, a life sciences solutions provider, reflect the state of the biopharmaceutical industry. Change_co shows sensitivity to R&D costs and storage of biological samples. This metric is important for analyzing volatility in the medical technology sector on System.GURU.Markets.
Daily change in the price of a set of shares in a market segment - Diagnostic medical equipment
Azenta, Inc. is a life sciences solutions provider. This chart shows the sector's average daily volatility. Comparison with AZTA, which focuses on sample management and cryostorage, helps to position it as a key infrastructure player.
Daily change in the price of a broad market stock, index - GURU.Markets
Azenta is a leading provider of life science solutions, including automated sample repositories and genomic services. Its business serves as a barometer of global scientific activity. The chart below illustrates general market fluctuations, which can be used to assess Azenta's stability.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Azenta Inc.
Azenta is a key provider of biological sample storage and transportation solutions for the life sciences sector. Its annual growth rate serves as a barometer of R&D investment in the biotech industry. The chart below provides a snapshot of this science-intensive business.
Annual dynamics of market capitalization of the market segment - Diagnostic medical equipment
Azenta, Inc. is a leading provider of automation and sample management solutions for the life sciences industry. Its products are critical for pharmaceutical and biotech companies. The chart below shows how its key role in this ecosystem and growing R&D budgets are driving its steady growth.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Azenta, a biological sample management company, operates in the protective sector. Demand from pharmaceutical companies and research centers is stable. The company's share price reflects a long-term trend toward life sciences, making it resilient to market cycles.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Azenta Inc.
Azenta, a life sciences company, is driven by R&D budgets in the pharmaceutical industry. The monthly fluctuations in the chart reflect demand for its biospecimen management solutions, which is closely tied to biotech funding levels and clinical trial activity.
Monthly dynamics of market capitalization of the market segment - Diagnostic medical equipment
Azenta, Inc. provides sample management solutions for the life sciences, from automated storage systems to genomic services. The dynamics of the diagnostic equipment sector, shown in the graph, reflect R&D spending in the pharmaceutical industry. This allows us to assess the demand for Azenta's services, critical for drug development, against the backdrop of overall trends.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Azenta provides sample management solutions for the life sciences, from automated storage systems to genomic services. Demand for its products is stable and supported by R&D spending. A chart of the overall market performance allows us to assess how much investors value this "defensive" characteristic, making Azenta shares less volatile than the overall market.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Azenta Inc.
Azenta, a provider of solutions for storing and analyzing biological samples, is a key player in the life sciences industry. Its weekly stock price reflects R&D spending in the pharmaceutical and biotech industries, demonstrating how the market perceives short-term demand for research infrastructure.
Weekly dynamics of market capitalization of the market segment - Diagnostic medical equipment
Azenta, as a life sciences service provider, is a barometer for the sector. The chart compares its performance with the industry, demonstrating how closely it is influenced by overall R&D spending trends among its client pharmaceutical and biotech companies.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Azenta provides solutions for storing and analyzing biological samples for the life sciences. Demand in this sector is stable. The chart will show whether Azenta shares act as a safe haven, demonstrating less volatility than the market due to consistent R&D spending in biotech.
Market capitalization of the company, segment and market as a whole
AZTA - Market capitalization of the company Azenta Inc.
Azenta's market capitalization is a financial barometer for the life sciences industry. This company, which provides solutions for storing and analyzing biological samples, reflects its investments in pharmaceutical and biotech research. Its performance reflects the belief that the future of medicine depends on the reliable management of valuable biological data.
AZTA - Share of the company's market capitalization Azenta Inc. within the market segment - Diagnostic medical equipment
Azenta provides sample management solutions for the life sciences, from automated storage systems to genomic services. Its market share reflects its critical role in the pharmaceutical research value chain. The chart below illustrates the extent to which scientific and biotech companies rely on Azenta's infrastructure solutions.
Market capitalization of the market segment - Diagnostic medical equipment
Azenta provides sample management solutions for the life sciences industry. The chart below shows the overall market capitalization of the entire biotech sector. Its growth reflects the increasing volume of research and the importance of secure storage and analysis of biological materials.
Market capitalization of all companies included in a broad market index - GURU.Markets
Azenta provides solutions for storing and analyzing biological samples, which is critical for the pharmaceutical industry. Its market capitalization chart reflects the value of these "libraries of life," demonstrating how cell and DNA storage infrastructure is becoming an increasingly important part of the global healthcare industry.
Book value capitalization of the company, segment and market as a whole
AZTA - Book value capitalization of the company Azenta Inc.
Azenta, a life sciences company, derives its book value from its biological sample storage equipment and automated systems. The chart below shows how the company is investing in high-tech infrastructure. Its growth reflects the strengthening of its R&D infrastructure.
AZTA - Share of the company's book capitalization Azenta Inc. within the market segment - Diagnostic medical equipment
Azenta provides solutions for storing and analyzing biological samples. Its business requires unique and expensive physical infrastructure, from cryogenic storage facilities to automated laboratories. The chart below shows the share of this critical infrastructure for life sciences.
Market segment balance sheet capitalization - Diagnostic medical equipment
Azenta provides solutions for the life sciences industry, including sample storage and laboratory automation. This requires specialized and expensive equipment. The book value chart will show how investments in high-tech physical assets shape its competitive advantage in this knowledge-intensive industry.
Book value of all companies included in the broad market index - GURU.Markets
Azenta's assets are critical infrastructure for life sciences. The company's book value comes from its automated ultra-low-temperature storage systems for biological samples and its production facilities. This is the physical foundation that ensures the safety of invaluable materials for pharmaceutical and biotech research.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Azenta Inc.
Azenta provides solutions for the storage and analysis of biological samples. The company owns specialized equipment and laboratories. Its market capitalization reflects its critical role in the drug development chain. Investors value its reputation and long-term contracts with leading pharmaceutical companies worldwide.
Market to book capitalization ratio in a market segment - Diagnostic medical equipment
Azenta provides solutions for the life sciences industry, where both sophisticated equipment and sample management services create value. The chart shows how the market values the synergies between these areas and the company's intellectual property over and above the value of its tangible assets, and how this compares to the life sciences sector.
Market to book capitalization ratio for the market as a whole
Azenta provides solutions for biomedical research, including sample storage. The business combines high-tech services and significant infrastructure. The company's valuation reflects both its technological leadership and its tangible assets. The chart shows how investors value this hybrid of science and logistics relative to the overall market.
Debts of the company, segment and market as a whole
AZTA - Company debts Azenta Inc.
Azenta's debt strategy in the life sciences sector is focused on technological strengthening and expansion. This chart shows the funds the company is raising to acquire advanced biospecimen management technologies and build high-tech storage facilities. Debt here represents an investment in pharmaceutical research infrastructure.
Market segment debts - Diagnostic medical equipment
Azenta provides solutions for the life sciences, including sample storage and genomic analysis. This sector requires significant investment in specialized equipment and laboratories. Debt is used here to expand infrastructure and acquire niche players. The chart below illustrates Azenta's financial strategy within the context of its industry.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Azenta Inc.
Azenta provides solutions for storing and analyzing biological samples for biomedical research, which requires specialized and expensive equipment. This chart shows how the company finances its capital expenditures. It helps investors understand how its debt load aligns with the stability of its long-term customers' cash flows.
Market segment debt to market segment book capitalization - Diagnostic medical equipment
Azenta provides sample management solutions for the life sciences, from automated storage to genomic services. This sector is critical to the pharmaceutical industry. The chart shows the overall debt burden in the industry, helping to understand how Azenta uses capital to finance its high-tech solutions and M&A transactions.
Debt to book value of all companies in the market
Azenta, a provider of life science solutions, is a vital part of the innovation ecosystem. This chart shows the market's overall leverage. It provides investors with context for understanding how general economic conditions and capital availability impact financing not only for Azenta itself but also for its biotech clients.
P/E of the company, segment and market as a whole
P/E - Azenta Inc.
Azenta provides solutions for storing and transporting biological samples for pharmaceutical and biotech companies. This chart shows how investors assess the company's role in the drug discovery pipeline. Its dynamics are influenced by the level of investment in research and development (R&D) in the life sciences industry worldwide.
P/E of the market segment - Diagnostic medical equipment
Azenta represents the biomedical equipment and services sector. This chart shows the average P/E for this knowledge-intensive industry. Comparing the company's P/E to this benchmark allows us to understand whether the market considers its biospecimen storage and analysis solutions more in-demand and integrated into the R&D process than competitors' offerings.
P/E of the market as a whole
Azenta provides solutions for the storage and analysis of biological samples, serving the life sciences sector. Its business depends on investment in pharmaceutical and biotech research. This chart reflects the market's risk appetite. It helps us understand whether Azenta is following the general trend in the healthcare sector or whether its valuation is driven by the specific demand for genomics services.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Azenta Inc.
Azenta provides sample management solutions for the life sciences industry, from cryopreservation to genomic services. This chart shows market expectations for increased investment in pharmaceutical and biotech research. The company's future profits are directly linked to its development of new drugs and treatments.
Future (projected) P/E of the market segment - Diagnostic medical equipment
Azenta provides solutions for the pharmaceutical industry to manage and store biological samples, which are critical for research. This chart compares market expectations for Azenta's future profitability with those of its industry. It helps understand how highly the market values its unique niche and long-term contracts with leading biopharmaceutical companies.
Future (projected) P/E of the market as a whole
Azenta provides sample management solutions for the life sciences industry, from automated storage to genomic services. For a company working on long-term scientific projects, the overall market backdrop shown in the chart is critical. Investor optimism ensures stable funding for R&D in biotech and pharmaceuticals, guaranteeing Azenta a steady flow of orders.
Profit of the company, segment and market as a whole
Company profit Azenta Inc.
Azenta provides solutions for the management and storage of biological samples for biomedical research. The company's profitability depends on R&D expenditures in the pharmaceutical and biotech industries. This graph illustrates how demand for automated storage systems and genomics services impacts cash flow and operational efficiency.
Profit of companies in the market segment - Diagnostic medical equipment
Azenta provides sample management solutions for the life sciences, from automated storage to genomic services. This graph, which reflects the segment's total revenue, demonstrates the importance of infrastructure for biotech. Azenta's effectiveness in ensuring the integrity and availability of biological samples directly impacts the speed and cost of research across the industry.
Overall market profit
Azenta is a key provider of solutions for the life sciences industry, including the storage and analysis of biological samples. While overall market revenues can be cyclical, investments in pharmaceutical research and development are long-term. Azenta benefits from this sustainable trend, providing critical infrastructure for future discoveries.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Azenta Inc.
Azenta provides solutions for the management and storage of biological samples in the life sciences. This chart shows analyst expectations for future profitability, which are driven by investment in pharmaceutical and biotech research. The increase in forecasts is driven by increased activity in drug development.
Future (predicted) profit of companies in the market segment - Diagnostic medical equipment
Azenta provides sample management solutions for the life sciences, from automated storage to genomic services. This chart shows future revenue forecasts for the diagnostic and medical equipment segment. It helps assess how Azenta's business, located at the intersection of biotechnology and automation, fits into overall industry trends.
Future (predicted) profit of the market as a whole
Azenta provides solutions for storing and analyzing biological samples for biomedical research. Demand for its services largely depends on the level of R&D funding in the pharmaceutical and biotech industries. This graph of the overall economic situation is important, as during periods of growth, investors and governments invest more actively in science, providing Azenta with a steady flow of orders.
P/S of the company, segment and market as a whole
P/S - Azenta Inc.
Azenta provides sample management solutions for the life sciences industry, from storage to transportation. This chart, comparing market value to revenue, demonstrates how investors value its unique position in the life sciences market. It reflects the premium for every dollar of sales generated in a niche critical to pharmaceutical research.
P/S market segment - Diagnostic medical equipment
Azenta accelerates scientific discovery in the life sciences by providing biological sample management services, from cryopreservation to genomic analysis. The company's revenue is generated by supporting pharmaceutical and biotech research. This metric reflects the average revenue estimate for the research-intensive services sector, helping to assess Azenta's position in the drug discovery chain.
P/S of the market as a whole
Azenta provides solutions for biological sample lifecycle management and genomic analysis, serving pharmaceutical and biotech companies. Demand for Azenta's services is growing alongside advances in the life sciences. This chart serves as a gauge of market sentiment, allowing one to assess how highly investors value biotech revenues compared to the market.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Azenta Inc.
Azenta provides sample management solutions for the life sciences industry, from storage to genomic analysis. This chart shows how investors view the company relative to its future revenue. It reflects expectations of increased investment in pharmaceutical research and development, which directly drives demand for Azenta's services and products.
Future (projected) P/S of the market segment - Diagnostic medical equipment
Azenta provides sample management solutions for the life sciences industry, from storage to lab automation. This chart compares the company's future revenue expectations with those for the overall sector. An above-average forecast may indicate confidence in increased R&D investment and the uniqueness of Azenta's offerings, while a below-average forecast may indicate competitive pressure and cyclicality.
Future (projected) P/S of the market as a whole
Azenta provides sample management solutions for the life sciences, from automated storage to genomic analysis. The company's growth depends on investment in pharmaceutical research and development. This market expectations chart shows how confident investors are in the future growth of the biotech and science-based sectors.
Sales of the company, segment and market as a whole
Company sales Azenta Inc.
This chart shows the revenue of Azenta, Inc., a company behind many scientific discoveries. Its revenue comes from selling automated biological sample management and storage systems to pharmaceutical and biotech companies. The growth reflects increased investment in research and development of new drugs.
Sales of companies in the market segment - Diagnostic medical equipment
Azenta provides biological sample management and storage solutions for the life sciences industry. The company's services are critical to pharmaceutical and biotech research. This chart illustrates the total revenue of the entire life sciences equipment and services market, in which Azenta holds a strong position.
Overall market sales
Azenta, Inc. provides solutions for the life sciences, including sample storage and genomic analysis. Demand for its services is driven by the level of R&D funding in the pharmaceutical and biotech industries. This graph, reflecting the overall state of the economy, influences the size of budgets allocated for scientific research. Economic growth facilitates increased investment in advanced medical research.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Azenta Inc.
Azenta, Inc. provides biomedical sample management solutions, including cryopreservation and genomic services, to the pharmaceutical industry. Its revenue is directly tied to biotech R&D spending. This chart reflects analyst forecasts for the pace of innovation and investment in the development of new drugs and treatments.
Future (projected) sales of companies in the market segment - Diagnostic medical equipment
Azenta provides solutions for the life sciences industry, including sample storage and genomic services. This chart shows revenue forecasts for key business areas. This allows investors to assess which segment—automated storage systems or analytical services—is expected to contribute most to the company's growth.
Future (projected) sales of the market as a whole
The overall economic forecasts shown in this chart shape Azenta's prospects. The company provides solutions for life sciences, including sample storage and analysis. The research and development budgets on which Azenta depends are closely tied to economic confidence and the willingness to make long-term investments.
Marginality of the company, segment and market as a whole
Company marginality Azenta Inc.
Azenta provides solutions for the life sciences industry, including automated biological sample management. This chart shows the profitability of the business, which is critical for pharmaceutical and biotech research. Profit is generated by demand for high-tech equipment and recurring revenue from services and consumables.
Market segment marginality - Diagnostic medical equipment
Azenta provides life science solutions, including automated biological sample storage and genomic services. The company's success depends on the profitability of its high-tech products and services for the pharmaceutical and biotech industries. This chart shows the average profitability in the sector, allowing one to assess Azenta's strength in the life sciences market.
Market marginality as a whole
Azenta provides solutions for storing and analyzing biological samples for biomedical research. Demand for the company's services depends on scientific funding. This graph reflects the overall economic health, which influences the R&D budgets of pharmaceutical companies and government institutions—Azenta's key clients.
Employees in the company, segment and market as a whole
Number of employees in the company Azenta Inc.
Azenta provides solutions for the management and storage of biological samples in the life sciences industry. This chart reflects the size of the team providing high-tech services to pharmaceutical and biotech companies. This growth reflects an expanding client base and increasing demand for automated systems critical to modern research.
Share of the company's employees Azenta Inc. within the market segment - Diagnostic medical equipment
Azenta provides sample management solutions for the life sciences, from storage to automation. This business requires highly skilled personnel. The data in the graph shows Azenta's share of all specialists in this niche industry, demonstrating its deep expertise and the scale of its operations supporting pharmaceutical research.
Number of employees in the market segment - Diagnostic medical equipment
Azenta provides solutions for the management and analysis of biological samples for biomedical research. This chart illustrates employment in the diagnostic equipment sector. The growing number of specialists in this niche indicates increased investment in R&D in the pharmaceutical and biotechnology industries, directly driving demand for Azenta's high-tech solutions and services.
Number of employees in the market as a whole
Azenta provides solutions for storing and analyzing biological samples for biomedical research. Their clients include research centers and pharmaceutical companies. Azenta's growth depends on R&D investments, not the overall economic situation. This chart shows the macro level, but Azenta's hiring is driven by the pace of scientific and genetic engineering advances.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Azenta Inc. (AZTA)
Azenta provides solutions for the life sciences, including sample storage and genomics. It's a high-tech business, requiring both sophisticated equipment and qualified specialists. This metric reflects the balance between the value of their technology and the need for personnel to provide critical scientific services.
Market capitalization per employee (in thousands of dollars) in the market segment - Diagnostic medical equipment
Azenta provides sample management solutions (e.g., biomaterial storage) and genomic services for the life sciences industry. They combine automated hardware (storage) with specialized services. This chart compares the market valuation of their technology and service model with industry benchmarks.
Market capitalization per employee (in thousands of dollars) for the overall market
Azenta provides sample management solutions for the life sciences. It's a high-tech business at the intersection of robotics, IT, and biology. The high market value per employee, visible in this chart, reflects the value of the intellectual property and automated systems created and maintained by a team of qualified specialists.
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Azenta Inc. (AZTA)
Azenta provides life science solutions, specializing in biological sample management (cryopreservation, genomics). It is a high-tech service business for the pharmaceutical and biotech industries. This metric demonstrates the company's profitability from its niche, mission-critical services, leveraging the work of its scientists and technical specialists.
Profit per employee (in thousands of dollars) in the market segment - Diagnostic medical equipment
Azenta is a B2B service company for life sciences. They provide outsourcing (sample storage, genomics) for pharmaceutical R&D. This graph shows the benchmark for the diagnostics sector. For this B2B service, the benchmark is moderate. It's a "trust-based business," where profit per employee (scientist) is generated by the "quality" and "reliability" of services.
Profit per employee (in thousands of dollars) for the market as a whole
Azenta provides sample management solutions for biomedical research. They offer everything from automated cold chain storage systems to genomic sequencing. They represent the intersection of engineering, IT, and science. This graph helps us understand the profitability per employee of this niche high-tech business serving the pharmaceutical and biotech industries.
Sales to employees of the company, segment and market as a whole
Sales per company employee Azenta Inc. (AZTA)
Azenta provides solutions for storing and analyzing biological samples in the pharmaceutical industry. It's a high-tech business, where sales per employee reflect the value of its services and the level of automation. The chart demonstrates how investments in advanced equipment and software enable the company to generate significant revenue with its skilled team.
Sales per employee in the market segment - Diagnostic medical equipment
Azenta provides cold chain solutions for the life sciences industry, from automated sample storage to genomic sequencing. It's a high-tech service. This graph shows how their team, which combines engineers, logisticians, and scientists, generates revenue. It's an indicator of how in demand their services are among pharmaceutical R&D departments.
Sales per employee for the market as a whole
Azenta (AZTA) provides solutions for the life sciences industry, specializing in sample management (cryostorage) and genomic services. This is critical infrastructure for pharmaceutical R&D. This chart reflects the effectiveness of their high-tech services. Automated storage systems (cryobanks) and high-throughput sequencing enable Azenta to process massive volumes of samples and data.
Short shares by company, segment and market as a whole
Shares shorted by company Azenta Inc. (AZTA)
Azenta provides solutions for the management and storage of biological samples (biobanking) and genomic services for pharmaceutical and biotech companies. This is a critical part of R&D in the life sciences. This chart reflects bearish bets. Investors betting on the stock may fear a slowdown in funding in the biotech sector, which will reduce demand for Azenta's services, or intense competition in the genomic analysis segment.
Shares shorted by market segment - Diagnostic medical equipment
Azenta (AZTA) provides solutions for the management and storage of biological samples (freezing, automation) for biotech and pharmaceutical companies. Their business depends on R&D activity. This chart measures the overall investor skepticism of the life sciences sector. If investors are betting against the industry, they likely expect a reduction in biotech funding, which will slow the pace of research and demand for Azenta's services.
Shares shorted by the overall market
Azenta (AZTA) is a biotech company providing R&D services (sample storage). This Short_All chart shows "risk aversion." This pessimism is drying up venture capital funding for biotechs (AZTA's clients). Ultimately, they have no money left for R&D, which is "killing" Azenta's main source of revenue.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Azenta Inc. (AZTA)
Azenta (formerly Brooks Automation) is fully focused on life sciences, providing solutions for storing and analyzing biological samples (cold chain). This chart measures how the market views this stable but growing sector. It shows when stocks are overbought on expectations of R&D growth in pharma or oversold on fears of a downturn.
RSI 14 Market Segment - Diagnostic medical equipment
Azenta is a company focused on the life sciences sector. They provide solutions for automated biological sample management (cryostorage) and genomic services. This metric measures the overall momentum of the biotech equipment sector and helps understand whether the entire segment is oversold amid shrinking R&D budgets.
RSI 14 for the overall market
Azenta (AZTA) provides cold storage solutions for biological samples. This chart shows that its business is "defensive." Biotech R&D (AZTA's clients) requires sample storage in both euphoria and panic. In times of panic, investors value this "consumable" business, which is not dependent on the success of the research itself.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast AZTA (Azenta Inc.)
Azenta provides sample management solutions for the life sciences industry, including cold chain storage and genomic analysis. This chart shows the average cost forecast by analysts. Their targets are based on growing R&D budgets in the pharmaceutical industry and demand for sequencing services.
The difference between the consensus estimate and the actual stock price AZTA (Azenta Inc.)
Azenta (AZTA) is a life science bank. They provide cryogenic storage (biobanking) and sample management (DNA, cells) for pharmaceutical companies. This chart shows the valuation of this R&D infrastructure. It measures the gap between the price and the consensus target, reflecting the potential analysts see for growth in the cell and gene therapy market.
Analyst consensus forecast for stock prices by market segment - Diagnostic medical equipment
Azenta (formerly Brooks Automation) is a company focused on biological sample storage and management solutions for the life sciences industry. This chart shows analysts' overall expectations for the diagnostic equipment sector. It reflects whether experts believe in the growth of biobanks and research requiring millions of samples.
Analysts' consensus forecast for the overall market share price
Azenta is the custodian of R&D. They are leaders in automated cryo-storage (cold chain) for samples in biotech and pharma. This graph, reflecting expert expectations, impacts their clients. If the market is pessimistic, risk appetite declines, biotech companies receive less money and cut R&D budgets.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Azenta Inc.
Azenta is a custodian in the scientific world. They provide critical services and equipment for cold chain management of biological samples (storage, automation, transportation) to R&D centers. This chart is a peak-and-shovel indicator for biotech. It likely aggregates global R&D spending and demand for their high-margin sample management services.
AKIMA Market Segment Index - Diagnostic medical equipment
Azenta (AZTA) is an unsung leader in life sciences; the company (formerly Brooks) specializes in two areas: lab automation (robots) and biological sample management (freezing and storage). This composite metric evaluates companies. The chart shows the sector average. This benchmark: how does this niche (R&D service) model (AZTA) differentiate it from the average competitor?
The AKIM Index for the overall market
Azenta is a provider of biological sample management solutions (cold storage, automation) for the life sciences. It's a "bank" for biomaterials. This chart, reflecting the market average, is just a backdrop. It helps assess how this "protective" infrastructure business for pharma stacks up against the backdrop of general macroeconomic fluctuations.